OmniAsset
Get app

OmniAsset › Mutual funds › WhiteOak Capital Pharma and Healthcare Fund

WhiteOak Capital Pharma and Healthcare Fund

Sectoral / Thematic fund benchmarked to BSE Healthcare TRI. Every figure below is read from one dated snapshot; what the snapshot cannot prove is left out, never estimated.

Latest NAV2 Sep 202616.876
CategorySectoral / Thematic
PlanRegular · Growth
Launched16 Jan 2024
Risk labelthe scheme's own riskometerVery High Risk
Legal benchmarkSEBI Tier-1BSE Healthcare TRI
Expense ratiodirect plan, a year2.78%
AUM₹509 Cr
Growth of ₹10,000₹16,7557 Feb 2024 to 2 Sep 2026
₹16,928₹15,102₹13,277₹11,451₹9,626Feb 2024Sep 2024May 2025Jan 2026Sep 2026
₹16,755 (+22.3% a year) WhiteOak Capital Pharma and Healthcare Fund

Performance (trailing, annualised)

1Y annualised22.32%

Point-to-point from the fund's own published NAV; a period the history does not span is left out.

SIP returns

SIP 1Y (₹10,000 a month)invested ₹1,20,000 → worth ₹1,42,21335.88%

₹10,000 on the first of every month, valued at the latest NAV, as an annualised rate (XIRR).

Calendar years

Calendar 20250.09%

Rolling returns

Rolling 1Y · average81 windows since 10 Feb 202515.61%
Rolling 1Y · median16.38%
Rolling 1Y · worst window-1.12%
Rolling 1Y · best window31.96%
Rolling 1Y · windows positive96%

Every window of that length in the published history, so one lucky start date cannot flatter the fund.

Risk

Volatility (3Y)14.36%
Downside deviation (3Y)10.08%
Maximum drawdown-15.62%

Management

Fund managerMr. Ramesh Mantri, Mr. Piyush Baranwal, Mr. Dheeresh Pathak, Mr. Ashish Agrawal, Ms. Trupti Agrawal
Managing since6 Feb 2024

Related

Source: the OmniAsset signed reference snapshot, as of 3 Sep 2026. Figures are deterministic; missing data is withheld, never estimated. See methodology and data sources. Not investment advice.

Research this fund and compare it — on your device.

Get OmniAsset on Google Play The mutual fund tracker